drugset / Trial / NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with Schizophrenia
Timeline
- Start
- 2026-09-03
- Primary completion
- 2029-03-03
- Completion
- 2029-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trospium | Small molecule | — | — |
| Subject | Xanomeline | Small molecule | — | — |